High Point--vTv Therapeutics.

PositionTRIAD REGION

HIGH POINT -- vTv Therapeutics raised $117 million in an initial public offering. Formerly TransTech Pharma, the drugmaker started trading at $14 on July 30; the price declined to $10 by mid-August. vTv plans to use the proceeds to develop products including treatments for Alzheimer's disease and Type 2...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT